/explore
|
You are here 
|
www.peoplespolicyproject.org | ||
| | | | |
aspe.hhs.gov
|
|
| | | | | The National Alzheimer's Project Act (NAPA) creates an important opportunity to build upon and leverage HHS programs and other federal efforts to help change the trajectory of Alzheimer's disease and related dementias (AD/ADRD). The law calls for a National Plan for AD/ADRD with input from a public-private Advisory Council on Alzheimer's Research, Care and Services. The Advisory Council makes recommendations to HHS for priority actions to expand, coordinate, and condense programs in order to improve the ... | |
| | | | |
greyenlightenment.com
|
|
| | | | | [AI summary] The author argues that while individuals should have access to weight loss drugs like Ozempic, a universal healthcare program for them would bankrupt the system due to exorbitant costs that do not justify the modest gains in life expectancy or quality of life. | |
| | | | |
www.keithhennessey.com
|
|
| | | | | The President and his allies ominously warn that the Ryan plan would "end Medicare as we know it." But let's be honest, how much do you really know about Medicare? If you're under age 65 there's a good chance that you know very little about the program. You have had no reason to, at least until | |
| | | | |
www.medicineuncensored.com
|
|
| | | Ozempic, which is the generic name for semaglutide, is a drug first approved for treating type 2 diabetes. Yet the fact that it promotes the loss of weight has attracted the interest of medical practitioners and those who fight against obesity. Responses from users of Ozempic who have integrated the drug into their weight | ||
